1Stockl KM, Le L, Zakharyan A, et al. Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor [ J]. Arch Intern Med, 2010,170(8) :704-710.
2Ray WA, Murray KT, Griffin MR, et al. Outcomes with concurrent use of clopidogrel and proton pump inhibitors: a cohort study [ J]. Ann Intern Med, 2010,152(6) :337-345.
4Siller-Matula JM, Spiel AO, Lang IM, et al. Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel [ J ]. Am Heart J, 2009,157( 1 ) :148.
二级参考文献17
1P Michael HO, Thomas M, Maddox, et al. Risk of adverse out- comes associated with concomitant use of clopidogrel and proto pump inhibitors following acute coronary syndrome.JAMA,2009, 301(9):937-944.
2Jeremy A, Rassen, Niteesh K, et al. Cardivascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome. Circulation, 2009,120:2322-2329.
3Kim KA, Park PW, Hong SJ, et al. The effect of CYP2C19 poly- morphism on the pharmacokinetics and pharmacodynamics of clopidogrel: a possible mechanism for clopidogrel resistance. Clin Pharmacol Ther, 2008,84(2) : 236-242.
4Li XQ ,Andersson TB, Ahlstrom M, et al. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomepra- zole, lansoprazole, pantoprazole, and rabeprazole on human cy- tochrome P450 activities.Drug Metab Dispos,2004,32(8):821-827.
5Radhofer-Wehe S. Pharmacokinetics and metabolism of the pro- ton pump inhibitor pantoprazole in man.Drug Today(Barc), 1999: 35(10):765-772.
6Stockl KM, Le L, Zakharyan A, et al. Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor. Arch Intern Med, 2010,170(8):704-710.
7Juurlink DN, Gomes T, Ko DT, et al. A population-baseed study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ,2009,180(7):713-718.
8Michael A, Gaglia Jr, Rebecca Torguson, et al. Relation of proton pump inhibitor use after percutaneous coronary intervention with drug-eluting stents to outcomes. AM J Cardiol,2010,105(6):833- 838.
9Ray WA, Murray KT, Griffin MR, et al. Outcomes with concurrent use of clopidogrel and proton pump inhibitors: a cohort study. Ann Intern Med, 2010,152(6):337-345.
10Kwok CS, Loke YK. Meta-analysis: the effects of proton pump in- hibitors on cardiovascular events and mortality in patients receiv- ing clopidogrel. Aliment Pharmacol Ther,2010,31(8):810-823.
